Structures by: Sabari V.
Total: 17
Methyl (6<i>R</i>*,6a<i>R</i>*,12b<i>R</i>*)-2,4-dimethyl-6-(2-methylphenyl)-1,3-dioxo-2,3,4,6a,7,12b-hexahydro-1<i>H</i>,6<i>H</i>-chromeno[4',3':4,5]pyrano[2,3-<i>d</i>]pyrimidine-6a-carboxylate
C25H24N2O6
IUCrData (2017) 2, 6 x170812
a=9.4087(5)Å b=15.5422(7)Å c=14.6143(7)Å
α=90.00° β=91.0770(10)° γ=90.00°
(1'<i>S</i>,12'<i>R</i>,13'<i>S</i>,17'<i>S</i>)-15',15'-Dimethyl-1,2-dihydro-11',14',16',18'-tetraoxa-7'-azaspiro[indole-3,8'-pentacyclo[10.6.0.0^2,9^.0^3,7^.0^13,17^]octadecane]-2,10'-dione
C22H24N2O6
Acta Crystallographica Section E (2013) 69, 4 o466
a=9.2737(5)Å b=11.6543(8)Å c=18.8489(14)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>,4<i>E</i>)-Ethyl 5-(2,4-dichlorophenylsulfonyl)penta-2,4-dienoate
C13H12Cl2O4S
Acta Crystallographica Section E (2013) 69, 9 o1387
a=5.773(5)Å b=9.939(5)Å c=13.268(5)Å
α=90.00° β=95.876(5)° γ=90.00°
Diethyl [(2-bromoanilino)(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)methyl]phosphonate
C26H27BrN3O3P
Acta Crystallographica Section E (2012) 68, 5 o1554
a=11.2553(6)Å b=23.9104(15)Å c=9.4741(5)Å
α=90.00° β=91.229(3)° γ=90.00°
(<i>Z</i>)-3-(2-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2283
a=8.4958(3)Å b=8.7197(3)Å c=10.0520(3)Å
α=101.9300(10)° β=95.179(2)° γ=90.314(2)°
(2<i>E</i>,2'<i>E</i>)-Dimethyl 2,2'-[(phenylazanediyl)bis(methylene)]bis(3-phenylacrylate)
C28H27NO4
Acta Crystallographica Section E (2012) 68, 7 o2265
a=9.9099(2)Å b=11.7327(2)Å c=12.4079(4)Å
α=101.131(2)° β=106.039(2)° γ=114.8170(10)°
5,5'-Methylenebis(2-isopropoxybenzaldehyde)
C21H24O4
Acta Crystallographica Section E (2012) 68, 7 o2199
a=26.337(9)Å b=28.349(10)Å c=4.990(2)Å
α=90.00° β=90.00° γ=90.00°
3-[(<i>Z</i>)-Benzylidene]-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2011) 67, 11 o3061
a=10.7711(9)Å b=7.8736(7)Å c=31.610(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl (<i>E</i>)-2-({2-[(<i>E</i>)-(hydroxyimino)methyl]phenoxy}methyl)- 3-phenylacrylate
C18H17NO4
Acta Crystallographica Section E (2012) 68, 3 o608
a=9.6463(4)Å b=7.7062(3)Å c=22.4675(9)Å
α=90.00° β=100.337(2)° γ=90.00°
(<i>E</i>)-2-({2-[(<i>E</i>)-(Hydroxyimino)methyl]phenoxy}methyl)- 3-<i>p</i>-tolylacrylonitrile
C18H16N2O2
Acta Crystallographica Section E (2012) 68, 3 o570
a=8.4851(2)Å b=9.3900(3)Å c=10.0779(3)Å
α=100.208(2)° β=90.7250(10)° γ=105.2060(10)°
(2<i>E</i>,4<i>E</i>)-Ethyl 5-(phenylsulfonyl)penta-2,4-dienoate
C13H14O4S
Acta Crystallographica Section E (2012) 68, 4 o1093
a=6.2525(3)Å b=7.8889(4)Å c=14.5049(7)Å
α=82.828(3)° β=87.261(2)° γ=72.426(2)°
(<i>Z</i>)-3-Benzyl-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2012) 68, 8 o2329
a=9.3409(6)Å b=11.7876(7)Å c=11.8310(6)Å
α=90.00° β=94.727(3)° γ=90.00°
1-(2-Carboxyethyl)-5-ethyl-2-methylpyridinium chloride
C11H16NO2,Cl
Acta Crystallographica Section E (2012) 68, 10 o2937
a=7.5013(4)Å b=9.0509(5)Å c=9.3452(5)Å
α=75.253(2)° β=80.985(2)° γ=72.047(2)°
(6b<i>S</i>*,14<i>R</i>*,14a<i>R</i>*)-Methyl 14-(4-methylphenyl)-7-oxo-6b,6c,7,12b,14,14a-hexahydro-1<i>H</i>- pyrano[3,2-<i>c</i>:5,4-<i>c</i>']dichromene-14a-carboxylate
C28H22O6
Acta Crystallographica Section E (2013) 69, 2 o267-o268
a=9.526(5)Å b=10.711(5)Å c=21.975(5)Å
α=90.0° β=97.397(5)° γ=90.0°
Diethyl [(2-chloroanilino)(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)methyl]phosphonate
C26H27ClN3O3P
Acta Crystallographica Section E (2013) 69, 2 o182
a=11.2379(3)Å b=23.7075(6)Å c=9.4570(2)Å
α=90.00° β=90.8090(10)° γ=90.00°
Ethyl (2<i>E</i>,4<i>E</i>)-5-(3-bromophenylsulfonyl)penta-2,4-dienoate
C13H13BrO4S
Acta Crystallographica Section E (2013) 69, 4 o488
a=27.883(5)Å b=6.001(5)Å c=17.256(5)Å
α=90.00° β=94.020(5)° γ=90.00°
3-Methyl-2-vinylpyridinium phosphate
C8H10N,H2O4P
Acta Crystallographica Section E (2013) 69, 4 o487
a=7.7089(6)Å b=16.3668(13)Å c=8.0649(6)Å
α=90.00° β=109.689(4)° γ=90.00°